Matthew K Fust
CIK 1397266 · EVP & Chief Financial Officer · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$15.62M
Companies
8
Total Filings
121
Lifetime Open-Market Net
-$14.43M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ATRA | Director | 30,188 | $10.41 | $314.3K | -$795.7K | 28 | 2026-06-11 |
| NMRA | Director | 27,839 | $1.78 | $49.6K | -$371.0K | 6 | 2026-05-29 |
| RARE | Director | 33,696 | $24.35 | $820.5K | -$2.21M | 22 | 2026-05-18 |
| CRNX | Director | 22,836 | $34.47 | $787.2K | -$3.70M | 16 | 2025-09-30 |
| DERM | Director | 5,051 | $6.34 | $32.0K | -$88.0K | 12 | 2019-12-26 |
| MGNX | Director | 7,424 | $3.96 | $29.4K | -$203.4K | 7 | 2019-05-20 |
| ONYX PHARMACEUTICALS INC (ONXX) Delisted | EVP & Chief Financial Officer | 40,303 | — | — | -$7.05M | 23 | 2013-08-12 |
| JAZZ | EVP, Chief Financial Officer | 58,948 | $230.56 | $13.59M | $0 | 5 | 2008-12-01 |
Recent Filings · Page 11 of 13
121 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-03-05 | ONYX PHARMACEUTICALS INC (ONXX) Delisted | Exer (M) | +2,211 | $76.2K | EDGAR |
| 2013-03-04 | ONYX PHARMACEUTICALS INC (ONXX) Delisted | Mixed | −5,000 | -$812.0K | EDGAR |
| 2013-01-11 | ONYX PHARMACEUTICALS INC (ONXX) Delisted | Mixed | −3,087 | -$620.4K | EDGAR |
| 2012-11-30 | ONYX PHARMACEUTICALS INC (ONXX) Delisted | Exer (M) | +966 | $33.3K | EDGAR |
| 2012-08-08 | ONYX PHARMACEUTICALS INC (ONXX) Delisted | Mixed | −4,517 | -$975.1K | EDGAR |
| 2012-07-27 | ONYX PHARMACEUTICALS INC (ONXX) Delisted | Sell (S) | −5,207 | -$385.2K | EDGAR |
| 2012-04-03 | ONYX PHARMACEUTICALS INC (ONXX) Delisted | Mixed | +24,573 | -$57.7K | EDGAR |
| 2012-03-06 | ONYX PHARMACEUTICALS INC (ONXX) Delisted | Sell (S) | −592 | -$22.2K | EDGAR |
| 2012-02-16 | ONYX PHARMACEUTICALS INC (ONXX) Delisted | Mixed | +5,000 | $172.4K | EDGAR |
| 2012-01-10 | ONYX PHARMACEUTICALS INC (ONXX) Delisted | Sell (S) | −1,789 | -$77.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.